DOE Patents title logo U.S. Department of Energy
Office of Scientific and Technical Information

Title: Lead-203 as a label for radioimaging

Abstract

A radiopharmaceutical composition comprising a radioactive isotope of lead (Pb-203) in combination with a pharmaceutical or an antibody or antibody fragment and a bifunctional chelating agent. These compositions are especially useful in the imaging and diagnosis of tumors and tumor metastases.

Inventors:
 [1];  [2]
  1. Setauket, NY
  2. Middle Island, NY
Issue Date:
Research Org.:
Brookhaven National Lab. (BNL), Upton, NY (United States)
Sponsoring Org.:
USDOE
OSTI Identifier:
875244
Patent Number(s):
H000735
Application Number:
07/175424
Assignee:
United States of America as represented by United States (Washington, DC)
DOE Contract Number:  
AC02-76CH00016
Resource Type:
Patent
Resource Relation:
Patent File Date: 1988 Mar 30
Country of Publication:
United States
Language:
English
Subject:
statutory invention registration; lead-203; label; radioimaging; radiopharmaceutical; composition; comprising; radioactive; isotope; lead; pb-203; combination; pharmaceutical; antibody; fragment; bifunctional; chelating; agent; compositions; especially; useful; imaging; diagnosis; tumors; tumor; metastases; bifunctional chelating; radioactive isotope; especially useful; composition comprising; chelating agent; radiopharmaceutical composition; antibody fragment; pharmaceutical composition; /424/

Citation Formats

Srivastava, Suresh C., and Meinken, George E. Lead-203 as a label for radioimaging. United States: N. p., 1990. Web.
Srivastava, Suresh C., & Meinken, George E. Lead-203 as a label for radioimaging. United States.
Srivastava, Suresh C., and Meinken, George E. Mon . "Lead-203 as a label for radioimaging". United States. https://www.osti.gov/servlets/purl/875244.
@article{osti_875244,
title = {Lead-203 as a label for radioimaging},
author = {Srivastava, Suresh C. and Meinken, George E.},
abstractNote = {A radiopharmaceutical composition comprising a radioactive isotope of lead (Pb-203) in combination with a pharmaceutical or an antibody or antibody fragment and a bifunctional chelating agent. These compositions are especially useful in the imaging and diagnosis of tumors and tumor metastases.},
doi = {},
journal = {},
number = ,
volume = ,
place = {United States},
year = {1990},
month = {1}
}